Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 3Sarcoma 2Plasma cell 2Dermatologic 2CNS 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Thrombocytopenia 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Liver Neoplasms 1Jacobs syndrome 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 324Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thrombopoietin × Gastrointestinal × Clear all
NCT00187109 2008-04-10

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

St. Jude Children's Research Hospital

Phase 1/2 Completed
40 enrolled
CNSClassical hematologyGastrointestinalSarcoma

Jacobs syndrome, Liver Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡